Galapagos | GLPG - Pre Tax Profit

Stock Price
24.52
Daily Change
-0.12 -0.49%
Monthly
-12.86%
Yearly
15.44%
Q2 Forecast
24.95

Galapagos reported EUR-221.49M in Pre-Tax Profit for its fiscal quarter ending in September of 2025.





Pre Tax Profit Change Date
argenx SE USD 386.05M 99.15M Sep/2025
AstraZeneca USD 3.24B 117M Sep/2025
Biogen USD 557.3M 186.7M Sep/2025
Genmab DKK 55M 427M Dec/2025
Gilead Sciences USD 3.64B 1.21B Sep/2025
GlaxoSmithKline GBP 1.23B 1.23B Dec/2025
GRIFOLS EUR 190.51M 20.03M Jun/2025
Hikma Pharmaceutical USD 147.5M 3.5M Jun/2025
Incyte USD 389.94M 92.37M Dec/2025
Merck EUR 1.29B 458.1M Sep/2025
Neurocrine Biosciences USD 239.4M 52.4M Dec/2025
Novartis USD 4.64B 445M Dec/2025
Roche Holding CHF 4.79B 3.01B Jun/2025
Sanofi EUR -1.16B 5.5B Dec/2025
UCB EUR 789M 427M Jun/2025
Vertex Pharmaceuticals USD 1.3B 15.8M Sep/2025